130 related articles for article (PubMed ID: 311881)
1. Cellular immunity in patients with epidermoid cancer of the head and neck.
Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
3. Immunological status of patients in carcinoma head and neck.
Vasenwala SM; Aziz M; Rattan A; Ahmad KN
Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
[TBL] [Abstract][Full Text] [Related]
4. Transference of cell mediated immunity in patients with head and neck cancer.
Vetto RM; Burger DR
Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
[TBL] [Abstract][Full Text] [Related]
5. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
Wara WM; Ammann AJ; Wara DW
Cancer Treat Rep; 1978 Nov; 62(11):1775-8. PubMed ID: 728896
[TBL] [Abstract][Full Text] [Related]
6. Active T-rosette-forming cells in the peripheral blood of cancer patients.
Kerman RH; Smith R; Stefani SS; Ezdinili EZ
Cancer Res; 1976 Sep; 36(9 pt.1):3274-8. PubMed ID: 1086131
[TBL] [Abstract][Full Text] [Related]
7. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
8. Levamisole in squamous cell carcinoma of the head and neck.
Olivari AJ; Glait HM; Guardo A; Califano L; Pradier R
Cancer Treat Rep; 1979 Jun; 63(6):983-90. PubMed ID: 380804
[TBL] [Abstract][Full Text] [Related]
9. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
Murray JL; Reuben JM; Smith TL; Gehan EA; Koretz SM; Hersh EM
J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501
[TBL] [Abstract][Full Text] [Related]
10. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
[No Abstract] [Full Text] [Related]
11. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
[TBL] [Abstract][Full Text] [Related]
12. Immune reactivity in primary carcinoma of the lung and its relation to prognosis.
Wanebo HJ; Rao B; Miyazawa N; Martini N; Middleman MP; Oettgen HF; Beattie EJ
J Thorac Cardiovasc Surg; 1976 Sep; 72(3):339-50. PubMed ID: 183063
[TBL] [Abstract][Full Text] [Related]
13. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
Browder JP; Chretien PB
Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
[No Abstract] [Full Text] [Related]
14. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
15. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
Zółtowska A; Skokowski J; Mlekodaj S; Boj E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
[TBL] [Abstract][Full Text] [Related]
17. ["Active" rosettes and skin tests to recall antigens and phytohemagglutinin in 48 patients with non metastatic squamous cell lung carcinoma and before treatment (author's transl)].
Lang JM; Pauli G; Roeslin N; Bigel P; Bessot JC
Rev Fr Mal Respir; 1980; 8(1):11-6. PubMed ID: 6970392
[TBL] [Abstract][Full Text] [Related]
18. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
Levo Y; Rotter V; Ramot B
Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
[TBL] [Abstract][Full Text] [Related]
19. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
Wolf GT; Carey TE
J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
Wanebo HJ; Hilal EY; Pinsky CM; Strong EW; Mike V; Hirshaut Y; Oettgen HF
Cancer Treat Rep; 1978 Nov; 62(11):1663-9. PubMed ID: 365322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]